Patients News | pharmaphorum

News

NICE backs AbbVie’s oral therapy for migraine prevention

AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and episodic migraine prevention to be recommended by NICE for NHS patients in England and W

News

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA

News

EU pharma reform package clears key Parliament vote

The European Parliament has voted through reforms to legislation regulating the pharma sector, which the industry claims could compromise competitiveness and patient care

News

Ubie AI aims to improve diagnosis of rare disease Cushing’s

People with the rare disease Cushing’s syndrome can sometimes take years to get a diagnosis, but a new project hopes to shorten that timeline with the help of artificial i

News

UK survey finds deep ethnic divisions in cancer diagnosis

A UK report has found that people from minority ethnic backgrounds face an average delay of a year between first noticing symptoms and gaining a diagnosis, which is more t

News

Sarah was born with ADA-SCID but was fortunate to access gene therapy via a clinical trial

NHS trust bids to take license for abandoned gene therapy

An NHS trust has taken the pioneering step of applying to hold the marketing authorisation for a gene therapy for a rare disease that was abandoned by a biotech developer

NICE backs AbbVie’s oral therapy for migraine prevention

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

EU pharma reform package clears key Parliament vote

Ubie AI aims to improve diagnosis of rare disease Cushing’s

UK survey finds deep ethnic divisions in cancer diagnosis

NHS trust bids to take license for abandoned gene therapy

AstraZeneca raises guidance on stellar cancer drugs growth

How to meet your physicians where they are online

News

Editor's Picks